Literature DB >> 28440703

Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency.

Wongsakorn Suchaoin1, Arshad Mahmood1, Kesinee Netsomboon2, Andreas Bernkop-Schnürch1.   

Abstract

AIM: The aim of this study was to develop zeta-potential-changing nanoparticles (NPs) combining cell-penetrating peptides for gene delivery. METHODS & MATERIALS: NPs were formed using phosphorylated carboxymethyl cellulose-glucosamine 6-phosphate (CMC-G6P) and polyethylene imine-polyarginine conjugates. Phosphate release was evaluated using intestinal alkaline phosphatase and cell lines. Transfection studies with plasmid DNA were then performed.
RESULTS: The zeta potential of CMC-G6P/branched PEI NPs was -3 mV and switched to +4 mV after intestinal alkaline phosphatase cleavage. The released phosphate in human colon adenocarcinoma cell line was more pronounced than human embryonic kidney cell line 293. Transfection studies demonstrated the greatest expression of plasmid DNA when being incorporated into CMC-G6P/polyethylene imine-polyarginine NPs.
CONCLUSION: Novel zeta potential changing NPs combining cell-penetrating peptides are a promising tool to deliver DNA drugs to target cells.

Entities:  

Keywords:  cell-penetrating peptide; intestinal alkaline phosphatase; polymeric nanoparticles; transfection efficiency; zeta potential changing systems

Mesh:

Substances:

Year:  2017        PMID: 28440703     DOI: 10.2217/nnm-2016-0345

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  2 in total

1.  Development and In Vitro Evaluation of Stearic Acid Phosphotyrosine Amide as New Excipient for Zeta Potential Changing Self-Emulsifying Drug Delivery Systems.

Authors:  Felix Prüfert; Franz Fischer; Christina Leichner; Sergey Zaichik; Andreas Bernkop-Schnürch
Journal:  Pharm Res       Date:  2020-04-06       Impact factor: 4.200

2.  GLUT1 targeting and hypoxia-activating polymer-drug conjugate-based micelle for tumor chemo-thermal therapy.

Authors:  Pengkai Ma; Guijie Wei; Jianhua Chen; Ziqi Jing; Xue Wang; Zhijun Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.